ROIVANT SCIENCES LTD. Lessee, Operating Lease, Liability, to be Paid, Year One
ROIVANT SCIENCES LTD. (ROIV) had Lessee, Operating Lease, Liability, to be Paid, Year One of $11.72 million as of 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-05-20
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $11.72M.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $10.32M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $10.70M.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $13.59M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-03-31 | $11.72M 10-K · filed 2026-05-20 |
| 2025-03-31 | $10.32M 10-K · filed 2025-05-29 |
| 2024-03-31 | $10.70M 10-K · filed 2024-05-30 |
| 2023-03-31 | $13.59M 10-K · filed 2023-06-28 |
| 2022-03-31 | $12.71M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |